Clinical trial
Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and…
NCT00282620 · Hartford Hospital, Other · Unknown status
Key facts
| NCT number | NCT00282620 |
|---|---|
| Title | Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life. |
| Official title | The Adjuvant Magnesium Trial (AdMag): Assessment if the Impact of Oral Magnesium on ICD Firing and Quality of Life |
| Lead sponsor | Hartford Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arrhythmia, Quality of Life, Hypomagnesemia |
| Intervention type | Drug |
| Interventions | Magnesium L-lactate |
| Enrollment | 240 |
| Start date | Jan 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Jan 27, 2006 |
| Last update posted | Nov 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: